TheFly.com
SNGX
Soligenix
$
()
Soligenix prices $4.75M public offering at 40c per share
Soligenix: FDA grants orphan drug designation for active ingredient in MarVax
Soligenix confirms FDA orphan designation for active ingredient in SuVax
Soligenix prophylaxis against Sudan Ebola Virus gets FDA orphan designation
Soligenix prevention against Marburg marburgvirus gets FDA orphan designation
Soligenix reaches agreement with EMA on second HyBryte trial
Soligenix forms Medical Advisory Board for Behcet's Disease
Soligenix files to sell 10.64M shares of common stock, warrants
Soligenix announces FDA Fast Track designation for dusquetide
Soligenix reports top-line results of Phase 2a study of SGX302 in psoriasis
Copyright ©1998-2024 Thefly.com LLC
